BioSpace News Archive

The cotinine screening devices market has progressed rapidly, catalyzed by technologies that enable rapid as well reliable detection of smoking status in patients.

According to the report, the global direct-to-consumer laboratory testing market was valued at US$ 2.4 Bn in 2020.

Automated cell culture systems have gained popularity for generating optimized cell lines across the entire spectrum ranging from seeding, feeding, passaging, to expansion of cells.

Basilea Pharmaceutica Ltd. announced that it has entered into an agreement with Moscow-based pharmaceutical company JSC Lancet for the distribution of Basilea’s antibiotic Zevtera® in Russia, as well as in the other countries of the Eurasian Economic Union.

Avacta Group plc is pleased to announce that Avacta Life Sciences’ diagnostics division has achieved ISO 13485 certification for the quality management system for the manufacture and distribution of Affimer reagents for use in lateral flow, ELISA and immunodiagnostic in-vitro diagnostic devices.

According to the report, the global smart patches market was valued at US$ 8.1 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031.

The transition from stainless-steel bioreactors to single-use bioreactors, as well as increased investment on research and development activities by biotechnology and pharmaceutical companies, are likely to drive growth of the global microcarrier market in the years to come.

Histology and cytology comprises investigating structure of tissues and cells respectively typically at the microscopic level, and the study includes both animals and plants.

The antimicrobial susceptibility test market survey offers insights into chief growth drivers and restrains impacting the overall growth trajectory.

argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, announced that it will host a virtual R&D Day on Tuesday, July 20, 2021 at 3:00 p.m. CET to highlight its ‘argenx 2025 vision’ and provide an update of its immunology pipeline.